Subgrouping Patients with Advanced NSCLC for Tailored Treatm

The panel discusses how patients with advanced NSCLC are sub-grouped in NSCLC and how to approach treatment for each group.

Related Keywords

, Small Cell Lung Cancer , Felcc , European Lung Cancer Conference , Nsclc , Lung Cancer , Non Small Cell Lung Cancer , Immunotherapy , Immunotherapy Nsclc , Advanced Nsclc Pd L1 Testing , Pd L1 Testing , Assays , Pd L1 Expression , Biomarkers , Molecular Testing ,